PTGX 8-K 2026-06-18

Protagonist Therapeutics, Inc (PTGX) 8-K dated 2026-06-18 — accession 0001104659-26-075777. This URL is the filing, not the PTGX hub.

Protagonist Therapeutics, Inc (PTGX) is a biotechnology company listed on NASDAQ.

Protagonist Therapeutics, Inc filed a 8-K on 2026-06-18. Accession 0001104659-26-075777.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PTGX revenue for 2025-12-31 was $46.0M. Net income was -$130.1M. Revenue was down 89.4% from 2024-12-31 to 2025-12-31. PTGX currently screens at market cap $7.25B.

Not investment advice. The PTGX SEC hub lists recent forms. The stock page is the research view.